Literature DB >> 7712012

Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.

I K Wright1, R Harling, D A Kendall, V G Wilson.   

Abstract

1. We have examined the effect of elevation of cellular adenosine 3':5'-cyclic monophosphate (cyclic AMP) on alpha 1- and alpha 2-adrenoceptor-mediated contraction of the isolated palmar lateral vein of the pig. Cellular cyclic AMP was increased by either inhibition of phosphodiesterase by rolipram, or direct activation of adenylyl cyclase by forskolin. 2. Noradrenaline (1 nM-10 microM) caused concentration-dependent contractions of the porcine isolated palmar lateral vein (pD2 7.32 +/- 0.07, n = 10). The selective alpha 1-adrenoceptor antagonist, prazosin (0.1 microM) and the selective alpha 2-adrenoceptor antagonist, rauwolscine (1 microM) caused a 10 fold rightward displacement of the concentration-response curve and a combination of the two antagonists caused a 200 fold rightward displacement of the concentration-response curve. The selective alpha 2-adrenoceptor agonist, UK-14304, also produced concentration-dependent contractions of the palmar lateral vein (pD2 7.70 +/- 0.15, n = 5), but the maximum response was 55.5 +/- 7.6% (n = 5) of that produced by noradrenaline. Prazosin (0.1 microM) failed to affect responses to UK-14304 but rauwolscine, 1 microM, caused a 200 fold rightward displacement. The estimated pKB value for rauwolscine (8.28 +/- 0.19, n = 10) is consistent with inhibition of alpha 2-adrenoceptors. Thus, the porcine isolated palmar lateral vein has a population of alpha 1- and alpha 2-adrenoceptors capable of producing a contraction. 3. Rolipram, 10 micro M, and forskolin, 1 micro M, caused a 2-3 fold rightward displacement of the noradrenaline concentration-response curve (CRC), but 1,9-dideoxyforskolin, 1 micro M, a forskolin analogue which does not activate adenylyl cyclase, failed to produce a significant inhibition of noradrenaline induced contractions. The combination of forskolin (1 micro M) and rolipram (10 micro M) were additive, producing a 20 fold rightward displacement of the noradrenaline CRC.4. Responses to noradrenaline were similarly affected by a combination of rolipram (10 micro M) and prazosin (0.1 micro M) (isolation of alpha 2-adrenoceptors) and the combination of rolipram (10 micro M) and rauwolscine(1 micro M) (isolation of alpha l-adrenoceptors), resulting in a 100 fold rightward displacement of the noradrenaline CRC. Although forskolin inhibited both alpha l- and alpha 2-adrenoceptor-mediated contractions,the effects produced were not similar. In particular, noradrenaline, 0.3-3 micro M, produced a significant contraction in the presence of forskolin (1 micro M) and prazosin (0.1 micro M) (an alpha 2-adrenoceptor-mediated response) but not in the presence of forskolin (1 micro M) and rauwolscine (1 micro M) (an alpha l-adrenoceptor mediated response).5. Five minute exposure to either rolipram (10 micro M) or forskolin (1 micro M) elevated [3H]-cyclic AMP of the porcine isolated palmar lateral vein by approximately 70% and 150-200%, respectively. Neither noradrenaline (1 nM- 100 micro M) nor UK-14304 (1 nM- 100 micro M) affected basal levels of [3H]-cyclic AMP,but both produced a concentration-dependent inhibition of forskolin-stimulated [3H]-cyclic AMP accumulation with a pKi of 7.43 +/- 0.1 (n = 3) and 7.97 +/- 0.18 (n = 3), respectively. The effect of noradrenaline against forskolin-stimulated [3H]-cyclic AMP accumulation was reversed by rauwolscine(1 micro M) but not by prazosin (0.1 micro M). In contrast, alpha 2-adrenoceptor activation did not affect rolipram induced elevation of [3H]-cyclic AMP.6. These findings indicate that M2-adrenoceptor contractions of the porcine isolated palmar lateral vein are not produced by reduction in cellular cyclic AMP per se. It is proposed that this response involves a novel signal transduction mechanism. However, when cellular cyclic AMP has been elevated by agents that stimulate adenylyl cyclase, rather than through inhibition of phosphodiesterase, the ability of alpha 2-adrenoceptors to inhibit cyclic AMP formation may be of functional importance in vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712012      PMCID: PMC1510157          DOI: 10.1111/j.1476-5381.1995.tb14920.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex.

Authors:  J Donaldson; A M Brown; S J Hill
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

Review 2.  Catecholamine action on smooth muscle.

Authors:  E Bülbring; T Tomita
Journal:  Pharmacol Rev       Date:  1987-03       Impact factor: 25.468

3.  Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels.

Authors:  B B Fredholm; I Jansen; L Edvinsson
Journal:  Acta Physiol Scand       Date:  1985-07

Review 4.  Forskolin: its biological and chemical properties.

Authors:  K B Seamon; J W Daly
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1986

5.  Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2-receptor antagonists.

Authors:  N P Shankley; J W Black; C R Ganellin; R C Mitchell
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

6.  "Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha 2-adrenergic agonists".

Authors:  J L Boyer; C Cárdenas; C Posadas; J A García-Sáinz
Journal:  Life Sci       Date:  1983-12-26       Impact factor: 5.037

7.  Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas.

Authors:  J Sadoshima; N Akaike; H Kanaide; M Nakamura
Journal:  Am J Physiol       Date:  1988-10

8.  Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.

Authors:  R R Ruffolo; E L Morgan; K Messick
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

9.  Mechanisms of relaxation induced by activation of beta-adrenoceptors in smooth muscle cells of the guinea-pig mesenteric artery.

Authors:  T Itoh; H Izumi; H Kuriyama
Journal:  J Physiol       Date:  1982-05       Impact factor: 5.182

10.  Postjunctional alpha-adrenoceptors in human superficial epigastric arteries and veins.

Authors:  T Sjöberg; S Steen; T Skärby; L Norgren; K E Andersson
Journal:  Pharmacol Toxicol       Date:  1987-01
View more
  9 in total

1.  Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes.

Authors:  S J MacLennan; P H Reynen; R S Martin; R M Eglen; G R Martin
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  A study of NPY-mediated contractions of the porcine isolated ear artery.

Authors:  R E Roberts; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats.

Authors:  K N Ting; N A Blaylock; D Sugden; P Delagrange; E Scalbert; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Role of the extracellular signal-regulated kinase (Erk) signal transduction cascade in alpha(2) adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein.

Authors:  R E Roberts
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Alpha 2-adrenoceptor mediated inhibition of forskolin-stimulated cyclic AMP accumulation in isolated porcine palmar lateral veins.

Authors:  I K Wright; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

6.  Enhancement of alpha2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: role of the ERK-MAP kinase signal transduction cascade.

Authors:  B Bhattacharya; R E Roberts
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  The mechanism of action of alpha 2-adrenoceptors in human isolated subcutaneous resistance arteries.

Authors:  N A Parkinson; A D Hughes
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

8.  Alpha 2 adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein: role of phosphatidylinositol 3-kinase and EGF receptor transactivation.

Authors:  R E Roberts
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction.

Authors:  M J Lew; S Flanders
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.